Zoeken op ZonMw
Zoeken op de website
Filters
De resultaten worden direct bijgewerkt zodra je een filter aanpast.
190
resultaten gevonden voor 'Policy'.
This thematic programme of the Dutch Research Agenda (NWA) focuses on the acceptance and implementation of existing animal-free models to assess whether substances are safe for humans.
Outsmarting cancer requires outstanding oncological research combined with an excellent valorisation strategy. This allows us to introduce new treatment methods into clinical practice as quickly as possible. We therefore contribute to the work of the Oncode Institute with our Oncode programme.
The grant policy applies to data files and other resources used to conduct the research, such as quantitative and qualitative data sources, the software to use data, and collections of physical resources like biological materials, audio and video recordings, etc.
Post-COVID, ook wel Long-COVID genoemd, verwijst naar de aanhoudende gezondheidsproblemen die sommige mensen ervaren na herstel van een besmetting met SARS-CoV-2, het virus dat de ziekte COVID-19 veroorzaakt.
Read which studies on ZonMw funds microplastics and nanoplastics. More knowledge is needed about the increasing health risks of microplastics.
The programme is designed to enhance the professionalism of nurses, carers and nursing specialists, thereby increasing the attractiveness of the profession and the quality of care.
Het PharmaNL programma omvat de twee programmalijnen Shared Development Infrastructure (SDI) en Human Capital Growth (HCG), die bijdragen aan succesvolle medicijninnovaties.
The starting point for Safety-II is that patient safety is increased by focusing on the adaptability and resilience of professionals in the context in which they work.
The ME/CFS research programme funds biomedical research on the causes, diagnosis and treatment of ME/CFS. The aim is to improve the health and quality of life of ME/CFS patients and their position in society.
With the programme More Knowledge with Fewer Animals (Dutch acronym: MKMD), we encourage the development of new animal-free models and the acceptance and implementation of existing animal-free research methods. Where that is not (yet) possible, we focus on the more effective use of results from animal experiments.
There is a gap between the needs of people with dementia and the provision of care and support. Read more about Social trials that tackles this challenge.